Reta-Tesa-AOD Lipolytic API tides for Institutions-Large Scale Fortune 500 Production RUO Blend

Reta-Tesa-AOD Lipolytic API tides for Institutions-Large Scale Fortune 500 Production RUO Blend

$1.00
Skip to product information
Reta-Tesa-AOD Lipolytic API tides for Institutions-Large Scale Fortune 500 Production RUO Blend

Reta-Tesa-AOD Lipolytic API tides for Institutions-Large Scale Fortune 500 Production RUO Blend

$1.00

Partner with an industry with specialized experience in peptide synthesis and chemistry. Our Pharma is GMP certified with approved documentation to support all levels of API distribution. At the heart of research for fat metabolism, studies on AOD9604 API Powder:  A modified fragment of Human Growth Hormone (HGH), heavily researched for its lipolytic (fat-burning) properties without affecting blood sugar or tissue growth. Tesamorelin API Powder: A growth hormone-releasing hormone (GHRH) analog studied for its ability to reduce visceral adiposity and improve lipid profiles. A massively significant outcome has been reported when these APIs are combined with Retatrutide API Powder (Tri-Agonist): The latest innovation in metabolic research, targeting GLP-1, GIP, and Glucagon receptors for maximum efficacy in obesity and lipid metabolism studies.

These Active APIs are available as a combined lyophilized powder in customized dosages or as individualized B2B-only products. Contact us for updated studies and pricing